Meningeal carcinomatosis in breast cancer: Prognostic factors and outcome

Journal of Neuro-Oncology

Volumn 104, Issue 2, 2011, Pages 565-572

  De Azevedo, Carla Rameri Alexandre Silva ^a   Cruz, Marcelo Rocha Sousa ^a   Chinen, Ludmilla Thomé Domingos ^a   Peres, Stela Verzinhasse ^b   Peterlevitz, Marcos Aurélio ^a   De Azevedo Pereira, Artur Eugênio ^b   Fanelli, Marcello Ferretti ^a   Gimenes, Daniel Luiz ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Breast cancer; Central nervous system; Leptomeninges; Meningeal carcinomatosis; Prognostic factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; METHOTREXATE; PROGESTERONE RECEPTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN METASTASIS; BREAST CANCER; BREAST CARCINOMA; CANCER GRADING; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER SURVIVAL; CARCINOMATOUS MENINGITIS; CEREBROSPINAL FLUID CYTOLOGY; CONTROLLED STUDY; CRANIAL NEUROPATHY; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACRANIAL HYPERTENSION; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROGNOSIS; SEIZURE; SURVIVAL TIME; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MENINGEAL CARCINOMATOSIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 80052636813     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0524-y     Document Type: Article

References (32)

1. S Paik S Shak G Tang, et al. 2004 A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2817 2826 15591335 10.1056/NEJMoa041588 1:CAS:528:DC%2BD2MXhslymsw%3D%3D (Pubitemid 40051905)
2. A Goldhirsch JN Ingle RD Gelber, et al. 2009 Thresholds for therapies: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2009 Ann Oncol 20 1319 1329 19535820 10.1093/annonc/mdp322 1:STN:280:DC%2BD1Mrjtlyhug%3D%3D
3. H Kennecke R Yerushalmi R Woods, et al. 2010 Metastatic behavior of breast cancer subtypes J Clin Oncol 28 3271 3277 20498394 10.1200/JCO.2009.25. 9820
4. MC Chamberlain 2005 Neoplasic meningitis J Clin Oncol 23 3605 3613 15908671 10.1200/JCO.2005.01.131
5. MC Chamberlain PRN Kormanik 1997 Carcinomatous meningitis secondary to breast cancer: predictors of response to combined modality therapy J Neurooncol 35 55 64 9266441 10.1023/A:1005803918194 1:STN:280:DyaK2svhtFClsQ%3D%3D (Pubitemid 27361846)
6. H Rudnicka A Niwińska M Murawska 2007 Breast cancer leptomeningeal metastasis-the role of multimodality treatment J Neurooncol 84 57 62 17310266 10.1007/s11060-007-9340-4 (Pubitemid 47103444)
7. F Andre K Slimane T Bachelot, et al. 2004 Breast cancer with synchronous metastasis: trends in survival during a 14-year period J Clin Oncol 22 3302 3308 15310773 10.1200/JCO.2004.08.095 (Pubitemid 41103686)
8. RJ Weil DC Palmieri JL Bronder AM Stark PS Steeg 2005 Breast cancer metastasis to the central nervous system Am J Pathol 167 913 920 16192626 10.1016/S0002-9440(10)61180-7 1:CAS:528:DC%2BD2MXhtFKqtLrP (Pubitemid 41416243)
9. W Boogerd AAM Hart JJV Sande E Engelsman 1991 Meningeal carcinomatosis in breast cancer Cancer 15 1685 1695 10.1002/1097-0142(19910315)67:6<1685::AID- CNCR2820670635>3.0.CO;2-M
10. J Bruna L Gonzalez J Miro, et al. 2009 Leptomeningeal carcinomatosis. Prognostic implications of clinical and cerebrospinal fluid features Cancer 115 381 389 19109820 10.1002/cncr.24041
11. F Waki M Ando A Takashima, et al. 2009 Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors J Neurooncol 93 205 212 19043775 10.1007/s11060-008-9758-3
12. MC Chamberlain SK Johnston MJ Glantz 2009 Neoplastic meningitis-related prognostic significance of the karnofsky performance status Arch Neurol 66 74 78 19139302 10.1001/archneurol.2008.506
13. MC Chamberlain PA Kormanik 1996 Prognostic significance of 111 indium-DTPA CSF flow studies in leptomeningeal metastases Neurology 46 1674 1677 8649568 1:STN:280:DyaK283kvV2rtQ%3D%3D
14. MC Chamberlain SK Johnston 2009 Neoplastic meningitis. Survival as a function of cerebrospinal fluid cytology Cancer 10.1002/cncr.24210
15. G Sze S Soletsky R Bronen G Krol 1989 MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis Am J Roentgenol 153 1039 1049 1:STN:280:DyaK3c%2FitlSltg%3D%3D (Pubitemid 19269378)
16. JM Gomori N Heching Tali Siegal 1998 Leptomeningeal metastases: evaluation by gadolinium enhanced spinal magnetic resonance imaging J Neurooncol 36 55 60 9525825 10.1023/A:1005783507544 1:STN:280:DyaK1c7osVOguw%3D%3D (Pubitemid 28230652)
17. HJ Bloom WW Richardson 1957 Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years Br J Cancer 11 359 377 13499785 10.1038/bjc.1957.43 1:STN:280:DyaG1c%2Fkt1Gmtg%3D%3D
18. EA Rakha ME El-Sayed AHS Lee, et al. 2008 Prognostic significance of Nottingham histologic grade in invasive breast carcinoma J Clin Oncol 26 3153 3158 18490649 10.1200/JCO.2007.15.5986
19. Rosen PP (1997) Rosen's breast pathology. Lippincott-Raven, Philadelphia, pp 275-293
20. GC Jayson A Howell M Harris, et al. 1994 Carcinomatous meningitis in breast cancer: an aggressive disease variant Cancer 74 3135 3141 7982179 10.1002/1097-0142(19941215)74:12<3135::AID-CNCR2820741212>3.0.CO;2-8 1:STN:280:DyaK2M%2FntlWkug%3D%3D (Pubitemid 24375070)
21. H Gauthier MN Guilhaume FC Bidard, et al. 2010 Survival of breast cancer patients with meningeal carcinomatosis Ann Oncol 10.1093/annonc/mdq232
22. K Fizazi B Asselain A Vincent-Salomon, et al. 1996 Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen Cancer 77 1315 1323 8608509 10.1002/(SICI)1097-0142(19960401)77:7<1315::AID- CNCR14>3.0.CO;2-4 1:STN:280:DyaK287pslChug%3D%3D (Pubitemid 26102330)
23. K Slimane F Andre S Delaloge, et al. 2004 Risk factors for brain relapse in patients with metastatic breast cancer Ann Oncol 15 1640 1644 15520065 10.1093/annonc/mdh432 1:STN:280:DC%2BD2crkslSksw%3D%3D (Pubitemid 39562604)
24. SL Hines LA Vallow WW Tan, et al. 2008 Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer Ann Oncol 19 1561 1565 18534964 10.1093/annonc/mdn283 1:STN:280:DC%2BD1crjtVWnug%3D%3D
25. S Dawood K Broglio FJ Esteva, et al. 2010 Survival of breast cancer patients with meningeal carcinomatosis Ann Oncol 21 2183 2187 10.1093/annonc/mdq232
26. EA Rakha M El-Sayed AR Green, et al. 2007 Prognostic markers in triple-negative breast cancer Cancer 109 25 32 17146782 10.1002/cncr.22381 1:CAS:528:DC%2BD2sXhtVKrtLY%3D (Pubitemid 46120191)
27. W Boogerd MJ van den Bent PJ Koehler, et al. 2004 The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomized study Eur J Cancer 40 2726 2733 15571954 10.1016/j.ejca.2004.08.012 1:CAS:528:DC%2BD2cXhtVahurvE (Pubitemid 39574724)
28. P Gaviani A Silvani E Corsini, et al. 2009 Neoplastic meningitis from breast carcinoma with complete response to liposomal cytarabine: case report Neurol Sci 30 251 254 19259616 10.1007/s10072-009-0044-8
29. MJ Glantz KA Jaeckle MC Chamberlain, et al. 1999 A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumours Clin Cancer Res 5 3394 3402 10589750 1:CAS:528:DyaK1MXotV2gsL0%3D
30. SA Grossman DM Finkelstein JC Ruckdeschel, et al. 1993 Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group J Clin Oncol 11 561 569 8445432 1:STN:280:DyaK3s7oslKqsA%3D%3D (Pubitemid 23071056)
31. HJ Stemmler M Schmitt N Harbeck, et al. 2006 Application of intrathecal trastuzumab (Herceptin™) for treatment of meningeal carcinomatosis in Her2-overexpression metastatic breast cancer Oncol Reports 15 1373 1377 1:CAS:528:DC%2BD28XksFKiurY%3D
32. P Feyer ML Sautter-Bihl W Budach, et al. 2010 DEGRO practical guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis Strahlenther Onkol 186 63 69 20127222 10.1007/s00066-010-2100-y